FIGURE 1
FROM:
A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma
Alok A Khorana, J D Rosenblatt, D M Sahasrabudhe, T Evans, M Ladrigan, D Marquis, K Rosell, T Whiteside, S Phillippe, B Acres, P Slos, P Squiban, M Ross and K Kendra
BACK TO ARTICLEFigure 1.

Schematic diagram describing the structure of the adenovirus gene therapy vector TG1041.
